Mya-Lecia Naylor’s biography, net worth, fact, career, awards and life story

Intro Brtitish actress, model, singer
Was Actor 
Model 
Singer 
Film actor 
Video blogger 
Internet personality 
YouTuber 
From United Kingdom 
Type Fashion 
Film, TV, Stage & Radio 
Internet 
Music 
Gender female
Birth 6 November 2002, Warwickshire, United Kingdom
Death 7 April 2019, London, UK
(aged 16 years)
Star sign Scorpio
Instruments:
Voice

Mya-Lecia Naylor (6 November 2002 – 7 April 2019) was an English actress, model and singer, known for her roles as Fran in the CBBC sitcom Millie Inbetween and Mya in the CBBC series Almost Never.

Early and personal life

Naylor was born on 6 November 2002 in Warwickshire, England to Zena and Martin Naylor. She lived in South Norwood in the London Borough of Croydon, with her parents and two younger brothers, Ellis and Oscar Naylor: Ellis was also an actor. She was educated at Royal Russell School and Coloma Convent Girls’ School.

Career

Naylor’s first television role was in 2004 in Absolutely Fabulous as Jane. In 2011, she played Tati in Tati’s Hotel and appeared in an episode of Cartoonito Tales as Little Red Riding Hood. In 2012, she appeared in two episodes of The Last Weekend. She then appeared in the film, Cloud Atlas as Miro. She appeared in Code Red as Miriam in 2013, and Index Zero in 2014. From 2014 to 2018, she appeared in Millie Inbetween as Fran. In 2015, she played Samantha Reasonable in the radio play Mr Reasonable. In 2019, she played Mya in CBBC’s comedy-drama, Almost Never.

Naylor was a member of the band angels N’ bandits.

Death

Naylor was found hanging in a marquee at her home on 7 April 2019 by her mother and was in cardiac arrest when emergency services were called to the address at 10am; Naylor was pronounced dead at 11.30am the same day at Croydon University Hospital. Naylor’s father stated that Naylor “had not been her normal self” due to stress of her upcoming GCSEs and was also grounded and banned from attending a party; Naylor’s father also added his belief “she was just making some sort of point” and “did not mean to do it”, calling it “a silly spur of the moment thing.” Croydon Coroner’s Court investigated the cause of her death and in September 2019, assistant coroner Toby Watkin believed Naylor did not intend to end her life and ruled Naylor died by misadventure. A memorial service for Naylor was held at Our Lady of The Annunciation Catholic Church in Croydon on 19 May 2019.

You May Also Like

Patrick Soon-Shiong’s net worth, biography, fact, career, awards and life story

Patrick Soon-Shiong net worth: Patrick Soon-Shiong is a South African-born surgeon and drug developer who has a net worth of $15.5 billion dollars. Patrick Soon-Shiong is currently the richest person in Los Angeles thanks to an extremely lucrative career as a biotech entrepreneur. In 2010, Patrick purchased Magic Johnson’s 4.5% ownership stake in the Los Angeles Lakers. He is the largest Lakers owner outside of the Buss family. With the transaction, Soon-Shiong also acquired four courtside Lakers seats. Soon-Shiong was born to Chinese immigrants in South Africa on July 29, 1952. His parents fled China during World War II and settled in Port Elizabeth, South Africa. After graduating from high school at the age of 16, Patrick earned his medical degree from the University of the Witwatersrand in Johannesburg at the age of 23. He then earned a Master of Science from the University of British Columbia before moving to Los Angeles for surgical training. Soon-Shiong, who now holds over 50 patents, was a member of the UCLA Medical School faculty from 1983 to 1991. From Humble Surgeon to Multi-Billionaire Soon-Shiong left UCLA in 1991 and founded a biotechnology company called Abraxis BioScience. Under Patrick’s leadership, the company eventually developed a revolutionary drug used in the treatment of breast, lung and pancreatic cancers. The drug, Abraxane, was approved by the FDA in 2005 and the European equivalent in 2008 for the treatment of breast cancer when chemotherapy was not working. By 2009, Abraxane generated $315 million in revenue per year. In 2010 Abraxis BioScience, which was still solely owned by Soon-Shiong, was acquired by American biotech company Celgene for $3 billion in cash and stock. Turns out, this acquisition wasn’t even his biggest success in the business world! In 1997, Patrick founded a company called American Pharmaceutical Partners (APP) which manufactured generic intravenous medicines. By 2008, APP was generating $750 million per year in revenue, of which roughly $300 million was pure profit. In July of 2008, Homberg, Germany-based Fresnius SE agreed to acquire APP for $5.6 billion. At the time of the transaction, Patrick Soon-Shiong owned 80% of APP’s shares. Not one to rest on his laurels, Soon-Shiong founded another company called NantWorks in September 2011. Nantworks’s health division NantHealth aims to provide cloud-based data to the healthcare industry. One of the company’s super computers is now able to analyze and transfer the genetic data from a tumor in under a minute.
Read More